Skip to Content

Fellowship

The Phase I Clinical Trials Fellowship Program (Department of Investigational Cancer Therapeutics) provides a one- to two-year experience in early drug development. Fellows will be trained in developing and conducting innovative clinical/translational trials with novel, targeted agents.

Fellows & FacultyMD Anderson Cancer Center provides a rich experience for fellows. Over 89,000 patients were seen here last year, and almost 12,000 were placed on therapeutic trials. In 2010, our department alone had over 118 therapeutic trials and enrolled about 1200 patients on our protocols. About one-third of our Phase I trials are first-in-human studies.

Drs. Kurzrock, Falchook, Janku, and Lisa Sheppard-Goodlett (Program Coordinator) and fellows of the Investigative Cancer Therapeutics, and their spouses attended Korean barbecue dinner hosted by Dr. Hong at the Seoul Garden.

There is a wealth of opportunity for interactions with a wide variety of investigators who are internationally known for their expertise in basic, translational and/or clinical science. Fellows will learn how to write trials, interact with sponsors, develop translational endpoints to understand drug impact and factors predicting response and host toxicity, present data at national or international meetings, analyze data and write/complete manuscripts.

The opportunity to obtain an M.S. or Ph.D. degree in Human Biology and Patient-Based Research is also available.

Requirements

Fellows should have:

  • An M.D. degree
  • Completed an internal medicine residency or equivalent training
  • An interest in a career in drug development
  • Although completion of medical oncologic training is not a requirement, fellows who have completed this training will be highly competitive for a fellowship position.

For questions or to apply for fellowship training, please contact:

Razelle Kurzrock, M.D.
Professor of Medicine
Division of Cancer Medicine
Chair, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
Anderson Clinical Faculty Chair for Cancer Treatment and Research
Director, Patient-Based Biological Research (MS/PhD Program)
Graduate School of Biomedical Sciences
University of Texas Health Science Center
Co-Director: Center for Clinical and Translational Sciences
P.O. Box 301402
Houston, TX 77030
Phone: 713-794-1226
Fax: 713-563-0566
E-mail: rkurzroc@mdanderson.org 

Denise De La Cruz Baum, M.Ed
Manager, Clinical Protocol Administration
Department of Investigational Cancer Therapeutics - Unit 455
Division of Cancer Medicine
P.O. Box 301402
Houston, TX 77230-1402
Phone: 713-563-0632
Fax: 713-792-0334
E-mail: ddbaum@mdanderson.org 


Resources

Appointments & Referrals

For a referral to clinical trials with a new targeted drug, call (713) 792-3699, or visit our Contact Information page.


© 2012 The University of Texas MD Anderson Cancer Center